Click the above link to access MM&M's first Leadership Exchange Uncut e-book, "The Agency-Client Relationship"
As the industry continues to evolve, so must the agency/client relationship. How can pharma clients and their partners collaborate successfully in the face of mounting pressures? James Chase chairs a candid discussion of seasoned execs from both sides
An esteemed panel of marketers from small biotech companies discusses the unique challenges and opportunities of bringing novel products to market. James Chase moderates the session
With pharma transforming more rapidly than ever, seven industry vets chart a road map for meeting a changed industry's challenges. James Chase led the discussion.
Pharma marketing is not without its flaws. Last month, seven seasoned industry execs discussed what they might change if they had a clean slate. James Chase kept the peace.
Industry experts discuss what it means to truly put patients first, where pharma often falls short and what can be done to rectify this. James Chase chairs the debate
Co-pay initiatives rank among the most hotly debated topics in healthcare marketing today. Pharmas and healthcare providers love them. Payers and PBMs... not so much. Why is that? James Chase takes the moderator's chair
Seven industry experts evaluate advances and opportunities in non-personal promotion to physicians, and debate whether brands really need to deploy sales forces. James Chase chairs the discussion
Seven digital healthcare experts discuss how to turn engaging content across multiple screens into meaningful brand experiences for HCP audiences. James Chase moderates
How can Marketing and Managed Markets evolve an already complex relationship to meet the new demands of payers? Our expert panel, led by James Chase, has plenty of candid suggestions
Choosing channels and creating an integrated campaign isn't easy, but our panel of experts can help. James Chase directs the discussion
Industry experts discuss definitions of success in patient education—and ways to measure its value. James Chase takes the chair
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.